Everolimus effective in neuroendocrine tumours

Everolimus can delay tumour growth in neuroendocrine tumours, researchers have told European Cancer Congress delegates.

The mTOR inhibitor had a significant effect in non-functional neuroendocrine tumours (NETs) which do not secrete a hormone, and hence are often asymptomatic and diagnosed late, said Professor James Yao of the University of Texas, USA.

About 80% of NETs fall into the non